...
首页> 外文期刊>Iranian Journal of Microbiology >Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients.
【24h】

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients.

机译:慢性阻塞性肺疾病(COPD)患者中肺炎支原体肺炎的定植和伊朗非HIV(+)免疫功能低下患者的肺炎性肺炎发生率。

获取原文
           

摘要

Background and Objectives: With increasing rate of immunodeficiency diseases in the world, opportunistic micro-organism such as Pneumocystis jirovecii (P. jirovecii) become more important. Little information is available on prevalence of this life- threatening microorganism in Iran. This study was designed to determine the colonization and the rate of active disease caused by P. jirovecii in two groups of Iranian immunosuppressed patients.Materials and Methods: Two hundred and fifty five pulmonary samples were collected from two groups of immunosuppress- ed patients to detect a 260bp fragment of mt LSU rRNA gene of P. jirovecii by nested PCR. The first group was COPD patients consumed oral, inhaled or injectable corticosteroid and the second group was patients with malignancies under chemotherapy. Both groups were referred to National Research Institute of Tuberculosis and Lung Disease and Imam Khomeini hospital because of pulmonary symptoms. All patients introduced to this project were confirmed HIV sera-negative by ELISA and western blot test. Results: The mean age of COPD patients was 66.5 ± 11 (41-88) years and all of them were men. The mean age of patients with malignancy (PMs) was 43 ± 11 (23-65) years and 51.6% were men. The P. jirovecii was colonized in 7 of 89 COPD patients (7.9%) and its DNA was isolated from 11 of 153 PMs (7.2%). The microorganism could cause active disease in 7 of 67 (10.5%) PMs who suffered from pneumonia.Conclusion: The study showed that P. jirovecii was one of colonizing agents in the COPD patients, but it could cause active disease in PMs. Generally, the microorganism can exist in the lung of non-HIV+ immunosuppressed patients. Therefore, it should be considered as a potential infective agent in non-HIV+ immunocompromised patients.
机译:背景与目的:随着世界上免疫缺陷病发病率的上升,机会微生物如吉氏肺孢子菌(P. jirovecii)变得越来越重要。关于这种威胁生命的微生物在伊朗的流行情况,几乎没有信息。本研究旨在确定两组伊朗免疫抑制患者的吉氏疟原虫定植和活动性疾病的发病率。材料与方法:从两组免疫抑制患者中采集255份肺样品,以检测巢式PCR扩增出吉氏疟原虫mt LSU rRNA基因的260bp片段。第一组是口服,吸入或注射皮质类固醇的COPD患者,第二组是化疗后的恶性肿瘤患者。两组均因肺部症状被转诊至国家结核和肺病研究所和伊玛目霍梅尼医院。引入该项目的所有患者均通过ELISA和Western blot检测证实为HIV血清阴性。结果:COPD患者的平均年龄为66.5±11(41-88)岁,均为男性。恶性肿瘤(PMs)患者的平均年龄为43±11(23-65)岁,男性为51.6%。在89例COPD患者中有7例(7.9%)感染了jirovecii假单胞菌,并从153例PM中的11例(7.2%)分离了其DNA。该微生物可引起67例(10.5%)肺炎患者中的7例活动性疾病。结论:研究表明,吉罗威氏肺炎菌是COPD患者的定植因子之一,但它可能导致PMs中的活动性疾病。通常,微生物可存在于非HIV +免疫抑制患者的肺部。因此,应将其视为非HIV +免疫功能低下患者的潜在感染剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号